Translate Bio Inc said that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA induced immune response in early-stage non-human primate studies.
In a regulatory filing, the company cited Sanofi’s presentation slides showing that the vaccine candidate induced neutralizing antibodies and T-cell responses in animal studies.
